- Richard S Cooper, chairman (rcooper@orion.it.luc.edu)a,
- Charles N Rotimi, assistant professora,
- Jay S Kaufman, research associatea,
- Walinjom FT Muna, chief of cardiologyb,
- George A Mensah, associate professor of medicinec
- a Department of Preventive Medicine and Epidemiology, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA
- b University of Health Sciences, Yaounde, Cameroon
- c Medical College of Georgia, Augusta, GA, USA
- Correspondence to: Dr Cooper
- Accepted 22 October 1997
Although enormous challenges persist in the control of infection in sub-Saharan Africa, non-communicable diseases are also important threats to the health of adult Africans. 1 2 Controversy exists, however, over the priority these conditions deserve in the competition for scarce resources. It has recently been argued that hypertension treatment, for example, should not be attempted in sub-Saharan Africa given the high costs.3 Unfortunately, these discussions take place in an information vacuum, since it is impossible to define the burden of chronic conditions in societies where health statistics are unavailable.4 Cohort studies may serve as a proxy for vital statistics and give approximate answers to questions on the usefulness of treatment for chronic disease.5 Hypertension is particularly suited to this model because it is easily diagnosed, highly prevalent, and information on outcomes is plentiful.
Although the relative risk of a cardiovascular event in people with high and normal blood pressure is similar in Africa and the United States, the absolute risk is up to 13 times greater in Africans
Summary points
In sub-Saharan Africa it is difficult to formulate and justify policy on treating chronic conditions such as hypertension as there are no health statistics from which to judge likely costs and benefits
Cohort studies on hypertension in Nigeria and Zimbabwe and epidemiological information show that between 10 and 20 million people in sub-Saharan Africa may have hypertension and that treatment could prevent around 250 000 deaths each year
Taking account of both relative risk and absolute risk of a cardiovascular event or death, a systolic pressure of 160 mm Hg is recommended as a threshold for treatment in Africa
The reduction in population attributable risk associated with treatment could be 2% in Africa compared with 0.15% in the Unites States—some 13 times higher
“Number needed to treat” analysis shows …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Transforming translation
Published 30 May 2012
Re: Bringing Nightingale down to size
Published 29 May 2012
Re: Avoid antimuscarinic drugs in people with dementia
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27